Senzime Ab · OMXSTO:SEZI
Senzime Ab — Q3 2026 Earnings Presentation
28 slides from Senzime Ab's earnings presentation, Oct 29, 2026
Slide 1: Q3 Quarterly Report July–September 2026
Q3 QUARTERLY REPORT JULY – SEPTEMBER 2026 1 SENZIME QUARTERLY REPORT Q3 2026
Slide 2: Continued strong sensor sales and growth in all regions
SENZIME Q3 2026: CONTINUED STRONG SENSOR SALES AND GROWTH IN ALL REGIONS. CLEAR PROGRESS TOWARDS PROFITABILITY. Sales by product group (TSEK) EBITDA by month 2026 (TSEK) 35 000 0 30 000 -2 000 25 000 -4 000 20 000 15 000 -6 000 10 000 -8 000 5 000 0 -10 000 Q3 2022 Q3 2023 Q3 2024 Q3 2025 Q3 2026 Ja
Slide 3: Quarterly Report Jul-Sep 2026
QUARTERLY REPORT JUL-SEP 2026 Q3 2026 (1 JULY – 30 SEPTEMBER) Q1-Q3 2026 (1 JANUARY – 30 SEPTEMBER) • Net Sales amounted to TSEK 30,099 (26,478), an increase of 14% • Net Sales amounted to TSEK 78,002 (75,673), an increase of 3% • Currency-adjusted net sales increased by 12% • Currency-adjusted net
Slide 4: KPI's Third Quarter 2026
KPI’S THIRD QUARTER 2026 Net Sales by region (MSEK) 35 Q3 (JUL-SEP) Q1-Q3 (JAN-SEP) TOT YEAR US market TSEK 2026 2025 2026 2025 2025 30 Other markets Net Sales 30,099 26,478 78,002 75,673 104,022 25 EBITDA -8,026 -19,395 -45,495 -63,806 -99,051 20 21 Profit (loss) after financial items -12,015 -26,2
Slide 5: Sales Overview Q3
SALES OVERVIEW Q3 Currency- Net Sales by product group (Q3) Net Sales by region (Q3) Reported adjusted Europe Q3 Jul-Sep TSEK 2026 2025 Growth Growth 13% US 20,989 19,293 9% 7% Devices/other 2,880 6,603 -56% -57% Disposables Disposables 18,109 12,690 43% 41% 83% RoW 17% Europe 4,035 3,356 20% 20% De
Slide 6: This is Senzime.
This is Senzime. Senzime is a global medical technology company that develops algorithm-based patient monitoring systems with the goal of eliminating anesthesia related complications in over 100 million patients every year. Our systems enable precision-based monitoring of patients during and after s
Slide 7: CEO comment: Growth in all regions and strong sensor sales
CEO comment: GROWTH IN ALL REGIONS AND STRONG SENSOR SALES. CLEAR PROGRESS TOWARDS PROFITABILITY. The third quarter demonstrates that our initiatives to strengthen We remain focused on converting our strong commercial pipeline into new installations while driving increased utilization of our existin
Slide 8: Significantly improved margins, lower costs and stronger cash flow
Significantly improved margins, lower costs and stronger cash flow We remain committed to our target of achieving positive cash flow within the fourth Our efforts to improve operational efficiency are now delivering clear financial results. quarter of 2026, while recognizing the challenges of fully
Slide 9: Comments to the Q3 report
Comments to the Q3 report Revenue and profit in the third quarter 2026 Revenue and profit January – September 2026 The group's net sales for the third quarter of 2026 amounted to TSEK 30,099 (26,478), an The Group’s net sales for the period January–September 2026 amounted to increase of 14 percent c
Slide 10: Financial position, cash flow and investments, stock options
Operating profit for the period amounted to TSEK -63,450, compared with TSEK -81,612 Financial position for the corresponding period of the previous year, an improvement of TSEK 18,162, or At the end of the period, the company’s cash and cash equivalents amounted to 22 percent. TSEK 28,715 (106,630)
Slide 11: Sustainability and significant events
Sustainability Senzime is strengthening its financing to support strategic OEM expansion and the path toward profitability. The company has strengthened its financing structure through a Senzime’s operations contribute to improved global health and patient safety by new, non-dilutive credit facility
Slide 12: Review and Board of Directors' certification
Review Auditor’s report This interim report has been subject to review by the company’s auditors. To the Board of directors in Senzime AB (publ), corporate identity number 556565-5734 Introduction Board of Directors’ certification We have conducted a limited review of the condensed interim financial
Slide 13: Condensed Consolidated Statement of Comprehensive Income
Condensed Consolidated Statement of Comprehensive Income Q3 Jan-Sep Full-year Amounts in SEK thousands Note 2026 2025 2026 2025 2025 Net sales 2 30,099 26,478 78,002 75,673 104,022 Cost of goods sold 3 -13,292 -15,261 -40,651 -43,139 -69,330 Gross profit (loss) 16,807 11,217 37,351 32,534 34,692 Dev
Slide 14: Condensed Consolidated Statement of Comprehensive Income
Condensed Consolidated Statement of Comprehensive Income Q3 Jan-Sep Full-year Amounts in SEK thousands Note 2026 2025 2026 2025 2025 Profit (-loss) for the period -11,254 -25,534 -55,125 -94,544 -137,419 Other comprehensive income Items reclassifiable to profit or loss Conversion differences 1,464 -
Slide 15: Condensed Consolidated Balance Sheet: Assets
Condensed Consolidated Balance Sheet Assets September 30 December 31 Amounts in SEK thousands 2026 2025 2025 ASSETS Non-current assets Intangible assets 222,679 223,125 219,000 Property plant and equipment 4,540 4,730 4,462 Rights of use 13,130 14,408 13,850 Other financial assets 4,258 4,432 4,614
Slide 16: Condensed Consolidated Balance Sheet: Equity and Liabilities
Condensed Consolidated Balance Sheet Equity and Liabilities September 30 December 31 Amounts in SEK thousands 2026 2025 2025 EQUITY AND LIABILITIES Equity 254,294 348,260 304,461 LIABILITIES Non-current liabilities Provisions 4,258 4,432 4,614 Interest-bearing liabilities 7,500 - - Lease liability 1
Slide 17: Condensed Consolidated Statement of Change in Equity
Condensed Consolidated Statement of Change in Equity Attributable to parent company´s shareholders Amounts in SEK thousands Share capital Other contributed capital Reserves Retained earnings incl.profit (loss) for the year Total equity Opening balance as of 1 January 2025 16,647 959,021 9,102 -638,9
Slide 18: Condensed Consolidated Statement of Cash Flow
Condensed Consolidated Statement of Cash Flow Q3 Jan-Sep Full-year Amounts in SEK thousands 2026 2025 2026 2025 2025 Cash flow from operating activities Earnings before interest and taxes -14,232 -25,425 -63,450 -81,612 -122,575 Adjustment for non-cash items Depreciation and amortization 6,206 6,030
Slide 19: Parent company Income Statement
Parent company Income Statement Q3 Jan-Sep Full-year Amounts in SEK thousands 2026 2025 2026 2025 2025 Net sales 13,956 17,129 36,042 63,440 82,827 Cost of goods sold -10,354 -12,385 -26,715 -34,856 -59,577 Gross profit (loss) 3,602 4,744 9,327 28,584 23,250 Development expenditure -3,320 -5,475 -11
Slide 20: Parent Company Balance Sheet: Assets
Parent Company Balance Sheet Assets September 30 December 31 Amounts in SEK thousands 2026 2025 2025 ASSETS Non-current assets Intangible fixed assets 64,303 57,924 60,743 Property plant and equipment 3,537 4,189 3,943 Financial assets 114,730 110,475 108,760 Total non-current assets 182,570 172,588
Slide 21: Parent Company Balance Sheet: Equity and Liabilities
Parent Company Balance Sheet Equity and Liabilities September 30 December 31 Amounts in SEK thousands 2026 2025 2025 EQUITY AND LIABILITIES Equity Restricted equtiy 87,686 81,027 83,981 Non-restricted equity 79,377 189,267 132,558 Total equity 167,063 270,294 216,539 LIABILITIES Interest-bearing lia
Slide 22: Notes on the consolidated accounts
Notes on the consolidated accounts Note 1. Accounting policies This interim report and summary for the third quarter ended 30 September 2026 has been prepared in accordance with the international accounting standard IAS 34 "Interim Financial Reporting". The term "IFRS" in this document encompasses t
Slide 23: Notes 3-5: Costs of goods sold and expenses
Note 3. Costs of goods sold Q3 Jan-Sep Full-year Amounts in SEK thousands 2026 2025 2026 2025 2025 Cost of materials 7,262 7,913 20,352 22,790 41,850 Personnel expenses 342 560 1,527 1,715 2,447 External services 76 1,374 2,580 2,888 4,145 Depreciation 5,612 5,414 16,192 15,746 20,888 Total 13,292 1
Slide 24: Note 6. Earnings per share
Note 6. Earnings per share Q3 Jan-Sep Full-year SEK 2026 2025 2026 2025 2025 Basic earnings per share -0.07 -0.16 -0.35 -0.66 -0.93 Diluted earnings per share -0.07 -0.16 -0.35 -0.66 -0.93 Performance measure used in the calculation of earnings per share Results attributable to the parent company's
Slide 25: Note 7. Share capital development
Note 7. Share capital development Date Event Number of shares Share capital (SEK) Quotient value (SEK) January 1, 2024 Opening balance 119,705,523 14,963, 190 0.125 October 18, 2024 Right share issue part 1 12,769,000 1,596,125 0.125 December 19, 2024 Right share issue part 2 700,000 87,500 0.125 Fe
Slide 26: Note 8. Alternative performance measures
Note 8. Alternative performance measures Senzime has defined alternative key figures as below. Calculations are published on the company's website www.senzime.com. Performance measure Definition Motive for use Gross margin excl. Gross profit (loss) excl. depreciations of intangible assets The group
Slide 27: Notes 9-11: Alternative performance measures, stock options, board
Note 9. Alternative performance measures Q3 Jan-Sep Full-year 2026 2025 2026 2025 2025 A Net sales, TSEK 30,099 26,478 78,002 75,673 104,022 B Gross profit excl. depreciations on intagible assets, TSEK 22,287 16,217 53,159 47,583 54,712 B/A Gross margin excl. depreciations on intagible assets (%) 74
Slide 28: Financial calendar and Contact
Financial calendar Contact Year-end report Q4 2026 18 Feb 2027 Philip Siberg, CEO Interim report Q1 2027 22 Apr 2027 Tel. +46 (0) 707 90 67 34 Annual report 2026 23 Apr 2027 e-post: [email protected] AGM 19 May 2027 Slavoljub Grujicic, CFO Tel. +46 (0) 763 06 60 11 e-post: slavoljub.grujicic